1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Central Nervous System Biomarkers Market
2.2. Global Central Nervous System Biomarkers Market, By Type
2.3. Global Central Nervous System Biomarkers Market, By End User
2.4. Global Central Nervous System Biomarkers Market, By Application
2.5. Global Central Nervous System Biomarkers Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Central Nervous System Biomarkers Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. End User
3.5.3. Application
3.5.4. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa
7. Global Central Nervous System Biomarkers Market, By Type
7.1. Global Central Nervous System Biomarkers Market Overview, by Type
7.1.1. Global Central Nervous System Biomarkers Market Revenue Share, By Type, 2022 Vs 2030 (in %)
7.2. Safety Biomarkers
7.2.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
7.3. Efficacy Biomarkers
7.3.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
7.4. Validation Biomarkers
7.4.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
8. Global Central Nervous System Biomarkers Market, By End User
8.1. Global Central Nervous System Biomarkers Market Overview, by End User
8.1.1. Global Central Nervous System Biomarkers Market, By End User, 2022 vs 2030 (in %)
8.2. Diagnostic Labs
8.2.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
8.3. Clinics/Hospitals
8.3.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
8.4. Research Centers
8.4.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
9. Global Central Nervous System Biomarkers Market, by Application, 2017-2030 (US$ Bn)
9.1. Global Central Nervous System Biomarkers Market Overview, by Application
9.1.1. Global Central Nervous System Biomarkers Market, By Application, 2022 vs 2030 (in%)
9.2. Drug Discovery & Development
9.2.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
9.3. Personalized Medicine
9.3.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
9.4. Others
9.4.1. Global Central Nervous System Biomarkers Market, By Region, 2017-2030 (US$ Bn)
10. Global Central Nervous System Biomarkers Market, By Region
10.1. Global Central Nervous System Biomarkers Market Overview, by Region
10.1.1. Global Central Nervous System Biomarkers Market, By Region, 2022 vs 2030 (in%)
10.2. Type
10.2.1. Global Central Nervous System Biomarkers Market, By Type, 2017-2030 (US$ Bn)
10.3. End User
10.3.1. Global Central Nervous System Biomarkers Market, By End User, 2017-2030 (US$ Bn)
10.4. Application
10.4.1. Global Central Nervous System Biomarkers Market, By Application, 2017-2030 (US$ Bn)
11. North America Central Nervous System Biomarkers Market Analysis
11.1. North America Central Nervous System Biomarkers Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Central Nervous System Biomarkers Market, by End User, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Central Nervous System Biomarkers Market, by Application, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Central Nervous System Biomarkers Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Central Nervous System Biomarkers Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.3.3. Canada Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
11.4.3.4. Canada Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12. Europe Central Nervous System Biomarkers Market Analysis
12.1. Europe Central Nervous System Biomarkers Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Central Nervous System Biomarkers Market, by End User, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Central Nervous System Biomarkers Market, by Application, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Central Nervous System Biomarkers Market, by Country, 2017-2030 (US$ Bn)
12.4.1. Europe Central Nervous System Biomarkers Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.2.3. Germany Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.2.4. Germany Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.3.3. France Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.3.4. France Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.4.3. UK Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.4.4. UK Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.5.3. Italy Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.5.4. Italy Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.6.3. Spain Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.6.4. Spain Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13. Asia Pacific Central Nervous System Biomarkers Market Analysis
13.1. Asia Pacific Central Nervous System Biomarkers Market, by Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Central Nervous System Biomarkers Market, by End User, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Central Nervous System Biomarkers Market, by Application, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Central Nervous System Biomarkers Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Central Nervous System Biomarkers Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.2.3. China Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.2.4. China Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.3.3. Japan Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.3.4. Japan Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.4.3. India Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.4.4. India Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
14. Latin America Central Nervous System Biomarkers Market Analysis
14.1. Latin America Central Nervous System Biomarkers Market, by Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Central Nervous System Biomarkers Market, by End User, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Central Nervous System Biomarkers Market, by Application, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Central Nervous System Biomarkers Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Central Nervous System Biomarkers Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
15. Middle East and Africa Central Nervous System Biomarkers Market Analysis
15.1. Middle East and Africa Central Nervous System Biomarkers Market, by Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Central Nervous System Biomarkers Market, by End User, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Central Nervous System Biomarkers Market, by Application, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Central Nervous System Biomarkers Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Central Nervous System Biomarkers Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Central Nervous System Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Central Nervous System Biomarkers, By Type, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Central Nervous System Biomarkers, By End User, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Central Nervous System Biomarkers, By Application, 2017-2030 (US$ Bn)
16. Company Profiles
16.1. Acumen Pharmaceuticals Inc
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. Alseres Pharmaceuticals Inc
16.3. Avacta Life Sciences Limited
16.4. bioMérieux (Banyan Biomarkers Inc)
16.5. Bio-Rad Laboratories Inc
16.6. G-Biosciences
16.7. Merck KGaA
16.8. Thermo Fisher Scientific Inc
16.9. Eli Lilly & Company (Avid Radiopharmaceuticals Inc)
16.10. Proteome Sciences PLC
16.11. Enzo Biochem Inc
16.12. H.U. Group Holdings
16.13. Acro Biosystems
List of Figures
FIG. 1 Global Central Nervous System Biomarkers Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Central Nervous System Biomarkers Market Segmentation
FIG. 4 Global Central Nervous System Biomarkers Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Central Nervous System Biomarkers Market, by End User, 2022 (US$ Bn)
FIG. 6 Global Central Nervous System Biomarkers Market, by Application, 2022 (US$ Bn)
FIG. 7 Global Central Nervous System Biomarkers Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2022
FIG. 9 Attractive Investment Proposition, by End User, 2022
FIG. 10 Attractive Investment Proposition, by Application, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Central Nervous System Biomarkers Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Central Nervous System Biomarkers Market Manufacturers, 2022
FIG. 14 Global Central Nervous System Biomarkers Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 15 Global Central Nervous System Biomarkers Market, by Safety Biomarkers, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Central Nervous System Biomarkers Market, by Efficacy Biomarkers, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Central Nervous System Biomarkers Market, by Validation Biomarkers, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Central Nervous System Biomarkers Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Central Nervous System Biomarkers Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 20 Global Central Nervous System Biomarkers Market, by Diagnostic Labs, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Central Nervous System Biomarkers Market, by Clinics/Hospitals, 2017-2030 (US$ Bn)
FIG. 22 Global Central Nervous System Biomarkers Market, by Research Centers, 2017-2030 (US$ Bn)
FIG. 23 Global Central Nervous System Biomarkers Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 24 Global Central Nervous System Biomarkers Market, by Drug Discovery & Development, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Central Nervous System Biomarkers Market, by Personalized Medicine, 2017-2030 (US$ Bn)
FIG. 26 Global Central Nervous System Biomarkers Market, by Others, 2017-2030 (US$ Bn)
FIG. 27 North America Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 28 U.S. Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 29 Canada Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 30 Europe Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 31 Germany Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 32 France Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 33 U.K. Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 34 Italy Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 35 Spain Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 36 Rest of Europe Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 37 Asia Pacific Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 38 China Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 39 Japan Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 40 India Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 41 South Korea Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 42 South-East Asia Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 43 Rest of Asia Pacific Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 44 Latin America Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 45 Brazil Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 46 Mexico Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 47 Rest of Latin America Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 48 Middle East & Africa Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 49 GCC Countries Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 50 South Africa Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 51 Rest of Middle East and Africa Central Nervous System Biomarkers Market, 2017-2030 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Central Nervous System Biomarkers Market
TABLE 2 Global Central Nervous System Biomarkers Market: Market Drivers Impact Analysis
TABLE 3 Global Central Nervous System Biomarkers Market: Market Restraints Impact Analysis
TABLE 4 Global Central Nervous System Biomarkers Market, by Competitive Benchmarking, 2022
TABLE 5 Global Central Nervous System Biomarkers Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Central Nervous System Biomarkers Market, by Key Strategies Analysis, 2022
TABLE 7 Global Central Nervous System Biomarkers Market, by Safety Biomarkers, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Central Nervous System Biomarkers Market, by Safety Biomarkers, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Central Nervous System Biomarkers Market, by Efficacy Biomarkers, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Central Nervous System Biomarkers Market, by Efficacy Biomarkers, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Central Nervous System Biomarkers Market, by Validation Biomarkers, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Central Nervous System Biomarkers Market, by Validation Biomarkers, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Central Nervous System Biomarkers Market, by Diagnostic Labs, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Central Nervous System Biomarkers Market, by Diagnostic Labs, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Central Nervous System Biomarkers Market, by Clinics/Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Central Nervous System Biomarkers Market, by Clinics/Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Central Nervous System Biomarkers Market, by Research Centers, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Central Nervous System Biomarkers Market, by Research Centers, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Central Nervous System Biomarkers Market, by Drug Discovery & Development, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Central Nervous System Biomarkers Market, by Drug Discovery & Development, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Central Nervous System Biomarkers Market, by Personalized Medicine, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Central Nervous System Biomarkers Market, by Personalized Medicine, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Central Nervous System Biomarkers Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Central Nervous System Biomarkers Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 26 Global Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 27 Global Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 28 Global Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 29 Global Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 30 Global Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 31 Global Central Nervous System Biomarkers Market, by Region, 2017-2022 (US$ Bn)
TABLE 32 Global Central Nervous System Biomarkers Market, by Region, 2023-2030 (US$ Bn)
TABLE 33 North America Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 34 North America Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 35 North America Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 36 North America Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 37 North America Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 38 North America Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 39 North America Central Nervous System Biomarkers Market, by Country, 2017-2022 (US$ Bn)
TABLE 40 North America Central Nervous System Biomarkers Market, by Country, 2023-2030 (US$ Bn)
TABLE 41 United States Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 42 United States Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 43 United States Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 44 United States Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 45 United States Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 46 United States Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 47 Canada Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 48 Canada Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 49 Canada Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 50 Canada Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 51 Canada Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 52 Canada Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 53 Mexico Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 54 Mexico Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 55 Mexico Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 56 Mexico Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 57 Mexico Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 58 Mexico Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 59 Europe Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 60 Europe Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 61 Europe Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 62 Europe Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 63 Europe Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 64 Europe Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 65 Europe Central Nervous System Biomarkers Market, by Country, 2017-2022 (US$ Bn)
TABLE 66 Europe Central Nervous System Biomarkers Market, by Country, 2023-2030 (US$ Bn)
TABLE 67 Germany Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 68 Germany Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 69 Germany Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 70 Germany Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 71 Germany Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 72 Germany Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 73 France Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 74 France Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 75 France Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 76 France Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 77 France Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 78 France Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 79 United Kingdom Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 80 United Kingdom Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 81 United Kingdom Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 82 United Kingdom Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 83 United Kingdom Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 84 United Kingdom Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 85 Italy Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 86 Italy Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 87 Italy Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 88 Italy Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 89 Italy Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 90 Italy Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 91 Spain Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 92 Spain Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 93 Spain Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 94 Spain Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 95 Spain Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 96 Spain Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 97 Rest of Europe Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 98 Rest of Europe Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 99 Rest of Europe Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 100 Rest of Europe Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 101 Rest of Europe Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 102 Rest of Europe Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 103 Asia Pacific Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 104 Asia Pacific Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 105 Asia Pacific Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 106 Asia Pacific Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 107 Asia Pacific Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 108 Asia Pacific Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 China Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 110 China Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 111 China Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 112 China Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 113 China Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 114 China Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 115 Japan Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 116 Japan Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 117 Japan Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 118 Japan Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 119 Japan Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 120 Japan Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 121 India Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 122 India Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 123 India Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 124 India Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 125 India Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 126 India Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 127 South Korea Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 128 South Korea Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 129 South Korea Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 130 South Korea Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 131 South Korea Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 132 South Korea Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 133 South-East Asia Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 134 South-East Asia Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 135 South-East Asia Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 136 South-East Asia Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 137 South-East Asia Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 138 South-East Asia Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 139 Rest of Asia Pacific Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 140 Rest of Asia Pacific Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 141 Rest of Asia Pacific Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 142 Rest of Asia Pacific Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 143 Rest of Asia Pacific Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 144 Rest of Asia Pacific Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 145 Latin America Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 146 Latin America Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 147 Latin America Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 148 Latin America Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 149 Latin America Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 150 Latin America Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 151 Brazil Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 152 Brazil Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 153 Brazil Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 154 Brazil Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 155 Brazil Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 156 Brazil Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 157 Argentina Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 158 Argentina Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 159 Argentina Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 160 Argentina Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 161 Argentina Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 162 Argentina Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 163 Rest of Latin America Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 164 Rest of Latin America Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 165 Rest of Latin America Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 166 Rest of Latin America Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 167 Rest of Latin America Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 168 Rest of Latin America Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 169 Middle East and Africa Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 170 Middle East and Africa Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 171 Middle East and Africa Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 172 Middle East and Africa Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 173 Middle East and Africa Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 174 Middle East and Africa Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 175 GCC Countries Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 176 GCC Countries Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 177 GCC Countries Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 178 GCC Countries Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 179 GCC Countries Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 180 GCC Countries Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 181 South Africa Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 182 South Africa Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 183 South Africa Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 184 South Africa Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 185 South Africa Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 186 South Africa Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)
TABLE 187 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by Type, 2017-2022 (US$ Bn)
TABLE 188 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by Type, 2023-2030 (US$ Bn)
TABLE 189 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by End User, 2017-2022 (US$ Bn)
TABLE 190 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by End User, 2023-2030 (US$ Bn)
TABLE 191 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by Application, 2017-2022 (US$ Bn)
TABLE 192 Rest of Middle East and Africa Central Nervous System Biomarkers Market, by Application, 2023-2030 (US$ Bn)